
    
      A Double-blind Placebo-controlled, Randomised, Single centre, First Time in Man Study to
      evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending
      Inhaled Doses of AZD7624 in Healthy Subjects
    
  